David L. Cooper

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Steven W. Pipe, Frank W.G. Leebeek, Michael Recht et al. · New England Journal of Medicine · 2023 · 343 citations · Full text

Medicine, Hematology, Molecular Medicine +16

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.

G J Dougherty, P M Landorp, David L. Cooper et al. · The Journal of Experimental Medicine · 1991 · 180 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

The evolution of alpha-fetoprotein and albumin. I. A comparison of the primary amino acid sequences of mammalian alpha-fetoprotein and albumin.

Michael B. Gorin, David L. Cooper, F Eiferman et al. · Journal of Biological Chemistry · 1981 · 150 citations · Full text

Life Sciences, Evolutionary Biology, Molecular Biology +17

Associations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia treatment center and health care provider services: results in adults with hemophilia in the HERO study

Angela Forsyth, Michelle Witkop, Angela Lambing et al. · Patient Preference and Adherence · 2015 · 125 citations · Full text

Pharmacy, Internal Medicine, Health Assessment +16

Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study

Michelle Witkop, Anne T. Neff, Tyler W. Buckner et al. · Haemophilia · 2017 · 124 citations · Full text

Medicine, Hematology, Internal Medicine +17